nodes	percent_of_prediction	percent_of_DWPC	metapath
Methysergide—HTR7—vagus nerve—esophageal cancer	0.0777	0.239	CbGeAlD
Methysergide—HTR2A—vagus nerve—esophageal cancer	0.0485	0.149	CbGeAlD
Methysergide—Telangiectasia—Methotrexate—esophageal cancer	0.019	0.0616	CcSEcCtD
Methysergide—HTR7—neck—esophageal cancer	0.017	0.0525	CbGeAlD
Methysergide—SIGMAR1—bronchus—esophageal cancer	0.0134	0.0412	CbGeAlD
Methysergide—SIGMAR1—smooth muscle tissue—esophageal cancer	0.0131	0.0403	CbGeAlD
Methysergide—HTR2B—smooth muscle tissue—esophageal cancer	0.0131	0.0402	CbGeAlD
Methysergide—SIGMAR1—trachea—esophageal cancer	0.012	0.037	CbGeAlD
Methysergide—HTR7—epithelium—esophageal cancer	0.0116	0.0357	CbGeAlD
Methysergide—HTR7—smooth muscle tissue—esophageal cancer	0.0112	0.0344	CbGeAlD
Methysergide—HTR2A—neck—esophageal cancer	0.0106	0.0328	CbGeAlD
Methysergide—HTR2B—digestive system—esophageal cancer	0.0103	0.0318	CbGeAlD
Methysergide—HTR7—trachea—esophageal cancer	0.0103	0.0316	CbGeAlD
Methysergide—HTR7—digestive system—esophageal cancer	0.00883	0.0272	CbGeAlD
Methysergide—SIGMAR1—lung—esophageal cancer	0.00863	0.0266	CbGeAlD
Methysergide—HTR2B—lung—esophageal cancer	0.00861	0.0265	CbGeAlD
Methysergide—Pain—Carboplatin—esophageal cancer	0.00847	0.0275	CcSEcCtD
Methysergide—Pleural effusion—Capecitabine—esophageal cancer	0.00783	0.0255	CcSEcCtD
Methysergide—Body temperature increased—Carboplatin—esophageal cancer	0.00783	0.0254	CcSEcCtD
Methysergide—Hyperaesthesia—Capecitabine—esophageal cancer	0.00764	0.0248	CcSEcCtD
Methysergide—HTR7—lung—esophageal cancer	0.00737	0.0227	CbGeAlD
Methysergide—HTR2A—epithelium—esophageal cancer	0.00723	0.0223	CbGeAlD
Methysergide—Ergonovine—ABCB1—esophageal cancer	0.00703	0.475	CrCbGaD
Methysergide—HTR2A—smooth muscle tissue—esophageal cancer	0.00697	0.0215	CbGeAlD
Methysergide—Polyuria—Cisplatin—esophageal cancer	0.00673	0.0219	CcSEcCtD
Methysergide—HTR2A—trachea—esophageal cancer	0.0064	0.0197	CbGeAlD
Methysergide—SIGMAR1—lymph node—esophageal cancer	0.0059	0.0182	CbGeAlD
Methysergide—HTR2B—lymph node—esophageal cancer	0.00589	0.0181	CbGeAlD
Methysergide—Pleural effusion—Methotrexate—esophageal cancer	0.00583	0.019	CcSEcCtD
Methysergide—HTR2A—digestive system—esophageal cancer	0.0055	0.017	CbGeAlD
Methysergide—Urine output increased—Capecitabine—esophageal cancer	0.00542	0.0176	CcSEcCtD
Methysergide—Orthostatic hypotension—Cisplatin—esophageal cancer	0.0054	0.0175	CcSEcCtD
Methysergide—Thrombophlebitis—Capecitabine—esophageal cancer	0.00503	0.0164	CcSEcCtD
Methysergide—Polyuria—Capecitabine—esophageal cancer	0.00496	0.0161	CcSEcCtD
Methysergide—Oliguria—Methotrexate—esophageal cancer	0.00485	0.0158	CcSEcCtD
Methysergide—HTR2A—lung—esophageal cancer	0.0046	0.0142	CbGeAlD
Methysergide—Pain in extremity—Capecitabine—esophageal cancer	0.00436	0.0142	CcSEcCtD
Methysergide—Ataxia—Capecitabine—esophageal cancer	0.0041	0.0133	CcSEcCtD
Methysergide—Urine output increased—Methotrexate—esophageal cancer	0.00404	0.0131	CcSEcCtD
Methysergide—Orthostatic hypotension—Capecitabine—esophageal cancer	0.00398	0.0129	CcSEcCtD
Methysergide—Ergotamine—ABCB1—esophageal cancer	0.00396	0.267	CrCbGaD
Methysergide—Bromocriptine—ABCB1—esophageal cancer	0.00382	0.258	CrCbGaD
Methysergide—Flushing—Cisplatin—esophageal cancer	0.00379	0.0123	CcSEcCtD
Methysergide—Thrombophlebitis—Methotrexate—esophageal cancer	0.00375	0.0122	CcSEcCtD
Methysergide—Polyuria—Methotrexate—esophageal cancer	0.00369	0.012	CcSEcCtD
Methysergide—Alopecia—Cisplatin—esophageal cancer	0.00361	0.0117	CcSEcCtD
Methysergide—Dysuria—Capecitabine—esophageal cancer	0.00352	0.0114	CcSEcCtD
Methysergide—Neutropenia—Capecitabine—esophageal cancer	0.00352	0.0114	CcSEcCtD
Methysergide—Weight increased—Capecitabine—esophageal cancer	0.00343	0.0111	CcSEcCtD
Methysergide—Weight decreased—Capecitabine—esophageal cancer	0.00341	0.0111	CcSEcCtD
Methysergide—Ill-defined disorder—Cisplatin—esophageal cancer	0.0033	0.0107	CcSEcCtD
Methysergide—Malaise—Cisplatin—esophageal cancer	0.00321	0.0104	CcSEcCtD
Methysergide—Convulsion—Cisplatin—esophageal cancer	0.00308	0.01	CcSEcCtD
Methysergide—Ataxia—Methotrexate—esophageal cancer	0.00305	0.00991	CcSEcCtD
Methysergide—Myalgia—Cisplatin—esophageal cancer	0.00303	0.00984	CcSEcCtD
Methysergide—Discomfort—Cisplatin—esophageal cancer	0.00299	0.00973	CcSEcCtD
Methysergide—Oedema peripheral—Capecitabine—esophageal cancer	0.00297	0.00965	CcSEcCtD
Methysergide—Oedema—Cisplatin—esophageal cancer	0.0029	0.00944	CcSEcCtD
Methysergide—Thrombocytopenia—Cisplatin—esophageal cancer	0.00284	0.00924	CcSEcCtD
Methysergide—Tachycardia—Cisplatin—esophageal cancer	0.00283	0.00921	CcSEcCtD
Methysergide—Flushing—Capecitabine—esophageal cancer	0.0028	0.00909	CcSEcCtD
Methysergide—Eosinophilia—Methotrexate—esophageal cancer	0.00277	0.00902	CcSEcCtD
Methysergide—Alopecia—Capecitabine—esophageal cancer	0.00266	0.00865	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00265	0.0086	CcSEcCtD
Methysergide—Dysuria—Methotrexate—esophageal cancer	0.00262	0.00852	CcSEcCtD
Methysergide—Neutropenia—Methotrexate—esophageal cancer	0.00262	0.00852	CcSEcCtD
Methysergide—Paraesthesia—Cisplatin—esophageal cancer	0.00261	0.00847	CcSEcCtD
Methysergide—Dyspnoea—Cisplatin—esophageal cancer	0.00259	0.00841	CcSEcCtD
Methysergide—Back pain—Capecitabine—esophageal cancer	0.00254	0.00825	CcSEcCtD
Methysergide—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00251	0.00815	CcSEcCtD
Methysergide—Drowsiness—Methotrexate—esophageal cancer	0.0025	0.00812	CcSEcCtD
Methysergide—Pain—Cisplatin—esophageal cancer	0.00248	0.00807	CcSEcCtD
Methysergide—Ill-defined disorder—Capecitabine—esophageal cancer	0.00243	0.00791	CcSEcCtD
Methysergide—Feeling abnormal—Cisplatin—esophageal cancer	0.00239	0.00778	CcSEcCtD
Methysergide—Malaise—Capecitabine—esophageal cancer	0.00237	0.00769	CcSEcCtD
Methysergide—Body temperature increased—Cisplatin—esophageal cancer	0.0023	0.00746	CcSEcCtD
Methysergide—Myalgia—Capecitabine—esophageal cancer	0.00223	0.00726	CcSEcCtD
Methysergide—Arthralgia—Capecitabine—esophageal cancer	0.00223	0.00726	CcSEcCtD
Methysergide—Chest pain—Capecitabine—esophageal cancer	0.00223	0.00726	CcSEcCtD
Methysergide—Discomfort—Capecitabine—esophageal cancer	0.00221	0.00717	CcSEcCtD
Methysergide—Oedema—Capecitabine—esophageal cancer	0.00214	0.00696	CcSEcCtD
Methysergide—Thrombocytopenia—Capecitabine—esophageal cancer	0.0021	0.00681	CcSEcCtD
Methysergide—Tachycardia—Capecitabine—esophageal cancer	0.00209	0.00679	CcSEcCtD
Methysergide—Asthenia—Cisplatin—esophageal cancer	0.00208	0.00677	CcSEcCtD
Methysergide—Diarrhoea—Cisplatin—esophageal cancer	0.00199	0.00646	CcSEcCtD
Methysergide—Alopecia—Methotrexate—esophageal cancer	0.00198	0.00644	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00195	0.00634	CcSEcCtD
Methysergide—Insomnia—Capecitabine—esophageal cancer	0.00194	0.00629	CcSEcCtD
Methysergide—Paraesthesia—Capecitabine—esophageal cancer	0.00192	0.00625	CcSEcCtD
Methysergide—Dyspnoea—Capecitabine—esophageal cancer	0.00191	0.0062	CcSEcCtD
Methysergide—Back pain—Methotrexate—esophageal cancer	0.00189	0.00614	CcSEcCtD
Methysergide—Dyspepsia—Capecitabine—esophageal cancer	0.00188	0.00612	CcSEcCtD
Methysergide—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00185	0.00601	CcSEcCtD
Methysergide—Vomiting—Cisplatin—esophageal cancer	0.00185	0.006	CcSEcCtD
Methysergide—Fatigue—Capecitabine—esophageal cancer	0.00185	0.006	CcSEcCtD
Methysergide—Rash—Cisplatin—esophageal cancer	0.00183	0.00595	CcSEcCtD
Methysergide—Constipation—Capecitabine—esophageal cancer	0.00183	0.00595	CcSEcCtD
Methysergide—Pain—Capecitabine—esophageal cancer	0.00183	0.00595	CcSEcCtD
Methysergide—Dermatitis—Cisplatin—esophageal cancer	0.00183	0.00595	CcSEcCtD
Methysergide—Ill-defined disorder—Methotrexate—esophageal cancer	0.00181	0.00589	CcSEcCtD
Methysergide—Feeling abnormal—Capecitabine—esophageal cancer	0.00176	0.00573	CcSEcCtD
Methysergide—Malaise—Methotrexate—esophageal cancer	0.00176	0.00572	CcSEcCtD
Methysergide—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00175	0.00569	CcSEcCtD
Methysergide—Nausea—Cisplatin—esophageal cancer	0.00172	0.00561	CcSEcCtD
Methysergide—Body temperature increased—Capecitabine—esophageal cancer	0.00169	0.0055	CcSEcCtD
Methysergide—Abdominal pain—Capecitabine—esophageal cancer	0.00169	0.0055	CcSEcCtD
Methysergide—Convulsion—Methotrexate—esophageal cancer	0.00169	0.0055	CcSEcCtD
Methysergide—Chest pain—Methotrexate—esophageal cancer	0.00166	0.0054	CcSEcCtD
Methysergide—Myalgia—Methotrexate—esophageal cancer	0.00166	0.0054	CcSEcCtD
Methysergide—Arthralgia—Methotrexate—esophageal cancer	0.00166	0.0054	CcSEcCtD
Methysergide—Discomfort—Methotrexate—esophageal cancer	0.00164	0.00534	CcSEcCtD
Methysergide—Thrombocytopenia—Methotrexate—esophageal cancer	0.00156	0.00507	CcSEcCtD
Methysergide—Asthenia—Capecitabine—esophageal cancer	0.00154	0.00499	CcSEcCtD
Methysergide—Diarrhoea—Capecitabine—esophageal cancer	0.00146	0.00476	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.00145	0.00472	CcSEcCtD
Methysergide—Insomnia—Methotrexate—esophageal cancer	0.00144	0.00468	CcSEcCtD
Methysergide—Paraesthesia—Methotrexate—esophageal cancer	0.00143	0.00465	CcSEcCtD
Methysergide—Dyspnoea—Methotrexate—esophageal cancer	0.00142	0.00462	CcSEcCtD
Methysergide—Somnolence—Methotrexate—esophageal cancer	0.00142	0.0046	CcSEcCtD
Methysergide—Dizziness—Capecitabine—esophageal cancer	0.00142	0.0046	CcSEcCtD
Methysergide—Dyspepsia—Methotrexate—esophageal cancer	0.0014	0.00456	CcSEcCtD
Methysergide—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.00138	0.00447	CcSEcCtD
Methysergide—Fatigue—Methotrexate—esophageal cancer	0.00137	0.00446	CcSEcCtD
Methysergide—Pain—Methotrexate—esophageal cancer	0.00136	0.00443	CcSEcCtD
Methysergide—Vomiting—Capecitabine—esophageal cancer	0.00136	0.00442	CcSEcCtD
Methysergide—Rash—Capecitabine—esophageal cancer	0.00135	0.00439	CcSEcCtD
Methysergide—Dermatitis—Capecitabine—esophageal cancer	0.00135	0.00438	CcSEcCtD
Methysergide—Feeling abnormal—Methotrexate—esophageal cancer	0.00131	0.00427	CcSEcCtD
Methysergide—Gastrointestinal pain—Methotrexate—esophageal cancer	0.0013	0.00423	CcSEcCtD
Methysergide—Nausea—Capecitabine—esophageal cancer	0.00127	0.00413	CcSEcCtD
Methysergide—Abdominal pain—Methotrexate—esophageal cancer	0.00126	0.00409	CcSEcCtD
Methysergide—Body temperature increased—Methotrexate—esophageal cancer	0.00126	0.00409	CcSEcCtD
Methysergide—Asthenia—Methotrexate—esophageal cancer	0.00114	0.00372	CcSEcCtD
Methysergide—Diarrhoea—Methotrexate—esophageal cancer	0.00109	0.00354	CcSEcCtD
Methysergide—Dizziness—Methotrexate—esophageal cancer	0.00105	0.00342	CcSEcCtD
Methysergide—Vomiting—Methotrexate—esophageal cancer	0.00101	0.00329	CcSEcCtD
Methysergide—Rash—Methotrexate—esophageal cancer	0.001	0.00327	CcSEcCtD
Methysergide—Dermatitis—Methotrexate—esophageal cancer	0.001	0.00326	CcSEcCtD
Methysergide—Nausea—Methotrexate—esophageal cancer	0.000947	0.00308	CcSEcCtD
Methysergide—HTR6—Signaling Pathways—SST—esophageal cancer	0.00021	0.000595	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—ANXA1—esophageal cancer	0.00021	0.000595	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—SST—esophageal cancer	0.00021	0.000595	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—SST—esophageal cancer	0.000208	0.000591	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000207	0.000587	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000206	0.000584	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—PDE4D—esophageal cancer	0.000205	0.000581	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—NOTCH3—esophageal cancer	0.000205	0.00058	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—GHRL—esophageal cancer	0.000205	0.00058	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—GHRL—esophageal cancer	0.000204	0.000579	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—NOTCH3—esophageal cancer	0.000204	0.000579	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—SST—esophageal cancer	0.000204	0.000578	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—PDE4D—esophageal cancer	0.000204	0.000578	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—GHRL—esophageal cancer	0.000203	0.000576	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—NOTCH3—esophageal cancer	0.000203	0.000576	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—FBXW7—esophageal cancer	0.000201	0.000571	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—FBXW7—esophageal cancer	0.000201	0.00057	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—FBXW7—esophageal cancer	0.0002	0.000566	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—GHRL—esophageal cancer	0.000199	0.000564	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—NOTCH3—esophageal cancer	0.000199	0.000564	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—ELMO1—esophageal cancer	0.000198	0.000562	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—PSME2—esophageal cancer	0.000198	0.000561	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—PSME1—esophageal cancer	0.000198	0.000561	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—ANXA1—esophageal cancer	0.000197	0.000559	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—HIF1A—esophageal cancer	0.000196	0.000555	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—FBXW7—esophageal cancer	0.000196	0.000555	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—GNG7—esophageal cancer	0.000195	0.000553	CbGpPWpGaD
Methysergide—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	0.000194	0.00055	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—GNG7—esophageal cancer	0.000194	0.00055	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—AKAP13—esophageal cancer	0.000194	0.000549	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—SST—esophageal cancer	0.000192	0.000543	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—KDR—esophageal cancer	0.000187	0.000531	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—GHRL—esophageal cancer	0.000187	0.00053	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—NOTCH3—esophageal cancer	0.000187	0.00053	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—HIF1A—esophageal cancer	0.000185	0.000523	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—FBXW7—esophageal cancer	0.000184	0.000521	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—NOTCH2—esophageal cancer	0.000184	0.00052	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—NOTCH2—esophageal cancer	0.000183	0.00052	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—XIAP—esophageal cancer	0.000183	0.000518	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—NOTCH2—esophageal cancer	0.000182	0.000516	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—XIAP—esophageal cancer	0.000182	0.000516	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000179	0.000507	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—NOTCH2—esophageal cancer	0.000178	0.000506	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—PDE4D—esophageal cancer	0.000177	0.000502	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—KDR—esophageal cancer	0.000177	0.0005	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—NOTCH1—esophageal cancer	0.000176	0.0005	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CTNNA1—esophageal cancer	0.000173	0.00049	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CTNNA1—esophageal cancer	0.000172	0.000488	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CXCL2—esophageal cancer	0.000172	0.000487	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CXCL2—esophageal cancer	0.000171	0.000485	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—GNG7—esophageal cancer	0.000169	0.000478	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—NOTCH2—esophageal cancer	0.000168	0.000475	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—NOTCH1—esophageal cancer	0.000166	0.000471	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—TGFBR2—esophageal cancer	0.000163	0.000462	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—TGFBR2—esophageal cancer	0.000163	0.000461	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—TGFBR2—esophageal cancer	0.000162	0.000458	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—PSME1—esophageal cancer	0.000161	0.000455	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—PSME2—esophageal cancer	0.000161	0.000455	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—CREBBP—esophageal cancer	0.00016	0.000453	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—ANXA1—esophageal cancer	0.00016	0.000453	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—PSME2—esophageal cancer	0.00016	0.000453	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—PSME1—esophageal cancer	0.00016	0.000453	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—ANXA1—esophageal cancer	0.000159	0.000451	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—TGFBR2—esophageal cancer	0.000158	0.000448	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—XIAP—esophageal cancer	0.000158	0.000448	CbGpPWpGaD
Methysergide—HTR1F—Signaling by GPCR—EGFR—esophageal cancer	0.000157	0.000445	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—SST—esophageal cancer	0.000155	0.000441	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—SST—esophageal cancer	0.000155	0.000438	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—SMAD4—esophageal cancer	0.000154	0.000437	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—SMAD4—esophageal cancer	0.000154	0.000436	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—SMAD4—esophageal cancer	0.000153	0.000434	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—GHRL—esophageal cancer	0.000152	0.000429	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—NOTCH3—esophageal cancer	0.000152	0.000429	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—CREBBP—esophageal cancer	0.000151	0.000427	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—NOTCH3—esophageal cancer	0.000151	0.000427	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—GHRL—esophageal cancer	0.000151	0.000427	CbGpPWpGaD
Methysergide—HTR1F—GPCR downstream signaling—PIK3CA—esophageal cancer	0.00015	0.000426	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—SMAD4—esophageal cancer	0.00015	0.000425	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CTNNA1—esophageal cancer	0.000149	0.000423	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—FBXW7—esophageal cancer	0.000149	0.000422	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—TGFBR2—esophageal cancer	0.000149	0.000421	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CXCL2—esophageal cancer	0.000149	0.000421	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—FBXW7—esophageal cancer	0.000148	0.00042	CbGpPWpGaD
Methysergide—HTR1E—Signaling by GPCR—EGFR—esophageal cancer	0.000148	0.00042	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—NOS3—esophageal cancer	0.000143	0.000406	CbGpPWpGaD
Methysergide—HTR1E—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000142	0.000401	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—SMAD4—esophageal cancer	0.000141	0.000399	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—PSME1—esophageal cancer	0.000139	0.000393	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—PSME2—esophageal cancer	0.000139	0.000393	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—ANXA1—esophageal cancer	0.000138	0.000391	CbGpPWpGaD
Methysergide—HTR1F—Signaling by GPCR—PIK3CA—esophageal cancer	0.000136	0.000386	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—NOTCH2—esophageal cancer	0.000136	0.000385	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—NOTCH2—esophageal cancer	0.000135	0.000383	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—NOS3—esophageal cancer	0.000135	0.000383	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—SST—esophageal cancer	0.000134	0.000381	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—ERBB2—esophageal cancer	0.000134	0.000379	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—GHRL—esophageal cancer	0.000131	0.000371	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—NOTCH3—esophageal cancer	0.000131	0.000371	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—FBXW7—esophageal cancer	0.000129	0.000365	CbGpPWpGaD
Methysergide—HTR1E—Signaling by GPCR—PIK3CA—esophageal cancer	0.000129	0.000365	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—ERBB2—esophageal cancer	0.000126	0.000358	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—HIF1A—esophageal cancer	0.000126	0.000357	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—HIF1A—esophageal cancer	0.000126	0.000357	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—HIF1A—esophageal cancer	0.000125	0.000355	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—HIF1A—esophageal cancer	0.000123	0.000347	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—KDR—esophageal cancer	0.000121	0.000342	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—TGFBR2—esophageal cancer	0.000121	0.000342	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—KDR—esophageal cancer	0.000121	0.000342	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—TGFBR2—esophageal cancer	0.00012	0.00034	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—KDR—esophageal cancer	0.00012	0.000339	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—CCND1—esophageal cancer	0.000118	0.000335	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—NOTCH2—esophageal cancer	0.000117	0.000333	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—KDR—esophageal cancer	0.000117	0.000332	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—HIF1A—esophageal cancer	0.000115	0.000326	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—CDKN1A—esophageal cancer	0.000114	0.000324	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—SMAD4—esophageal cancer	0.000114	0.000323	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—NOTCH1—esophageal cancer	0.000114	0.000322	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—SMAD4—esophageal cancer	0.000114	0.000322	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—NOTCH1—esophageal cancer	0.000114	0.000322	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—NOTCH1—esophageal cancer	0.000113	0.00032	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—CCND1—esophageal cancer	0.000112	0.000316	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—NOTCH1—esophageal cancer	0.00011	0.000313	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—KDR—esophageal cancer	0.00011	0.000312	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—EP300—esophageal cancer	0.000109	0.000309	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—CDKN1A—esophageal cancer	0.000108	0.000306	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—TGFBR2—esophageal cancer	0.000104	0.000295	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—NOTCH1—esophageal cancer	0.000104	0.000294	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—CREBBP—esophageal cancer	0.000103	0.000292	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—CREBBP—esophageal cancer	0.000103	0.000292	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—EP300—esophageal cancer	0.000103	0.000291	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—CREBBP—esophageal cancer	0.000102	0.00029	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—EGFR—esophageal cancer	0.000101	0.000287	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—EGFR—esophageal cancer	0.000101	0.000287	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—EGFR—esophageal cancer	0.0001	0.000285	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—CREBBP—esophageal cancer	0.0001	0.000284	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—SMAD4—esophageal cancer	9.86e-05	0.000279	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—EGFR—esophageal cancer	9.84e-05	0.000279	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—PIK3CA—esophageal cancer	9.68e-05	0.000274	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—PIK3CA—esophageal cancer	9.67e-05	0.000274	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—PIK3CA—esophageal cancer	9.6e-05	0.000272	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—MYC—esophageal cancer	9.49e-05	0.000269	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—CREBBP—esophageal cancer	9.41e-05	0.000267	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—PIK3CA—esophageal cancer	9.4e-05	0.000266	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—HIF1A—esophageal cancer	9.34e-05	0.000265	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—HIF1A—esophageal cancer	9.29e-05	0.000263	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—EGFR—esophageal cancer	9.28e-05	0.000263	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—EGFR—esophageal cancer	9.24e-05	0.000262	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—NOS3—esophageal cancer	9.23e-05	0.000261	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—NOS3—esophageal cancer	9.22e-05	0.000261	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—NOS3—esophageal cancer	9.16e-05	0.000259	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—NOS3—esophageal cancer	8.96e-05	0.000254	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—MYC—esophageal cancer	8.95e-05	0.000254	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—KDR—esophageal cancer	8.93e-05	0.000253	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—KDR—esophageal cancer	8.88e-05	0.000252	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—PIK3CA—esophageal cancer	8.83e-05	0.00025	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—PIK3CA—esophageal cancer	8.79e-05	0.000249	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—PIK3CA—esophageal cancer	8.78e-05	0.000249	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—EGFR—esophageal cancer	8.76e-05	0.000248	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—PIK3CA—esophageal cancer	8.72e-05	0.000247	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—ERBB2—esophageal cancer	8.63e-05	0.000245	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—ERBB2—esophageal cancer	8.62e-05	0.000244	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—ERBB2—esophageal cancer	8.56e-05	0.000243	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—PIK3CA—esophageal cancer	8.54e-05	0.000242	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—NOS3—esophageal cancer	8.42e-05	0.000239	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—NOTCH1—esophageal cancer	8.41e-05	0.000238	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—ERBB2—esophageal cancer	8.39e-05	0.000238	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—NOTCH1—esophageal cancer	8.37e-05	0.000237	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—HIF1A—esophageal cancer	8.07e-05	0.000229	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—PIK3CA—esophageal cancer	8.06e-05	0.000228	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—PIK3CA—esophageal cancer	8.02e-05	0.000227	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—ERBB2—esophageal cancer	7.88e-05	0.000223	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—TP53—esophageal cancer	7.79e-05	0.000221	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—KDR—esophageal cancer	7.72e-05	0.000219	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CREBBP—esophageal cancer	7.63e-05	0.000216	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—CCND1—esophageal cancer	7.62e-05	0.000216	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—CCND1—esophageal cancer	7.62e-05	0.000216	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—PIK3CA—esophageal cancer	7.6e-05	0.000215	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CREBBP—esophageal cancer	7.59e-05	0.000215	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—CCND1—esophageal cancer	7.57e-05	0.000214	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—EGFR—esophageal cancer	7.5e-05	0.000212	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—EGFR—esophageal cancer	7.46e-05	0.000211	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—CCND1—esophageal cancer	7.41e-05	0.00021	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—CDKN1A—esophageal cancer	7.38e-05	0.000209	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—CDKN1A—esophageal cancer	7.37e-05	0.000209	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—TP53—esophageal cancer	7.35e-05	0.000208	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—CDKN1A—esophageal cancer	7.32e-05	0.000207	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—NOTCH1—esophageal cancer	7.27e-05	0.000206	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—CDKN1A—esophageal cancer	7.17e-05	0.000203	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—PIK3CA—esophageal cancer	7.16e-05	0.000203	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—PIK3CA—esophageal cancer	7.13e-05	0.000202	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—EP300—esophageal cancer	7.02e-05	0.000199	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—EP300—esophageal cancer	7.01e-05	0.000199	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—EP300—esophageal cancer	6.96e-05	0.000197	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—CCND1—esophageal cancer	6.96e-05	0.000197	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—NOS3—esophageal cancer	6.83e-05	0.000194	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—EP300—esophageal cancer	6.82e-05	0.000193	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—NOS3—esophageal cancer	6.79e-05	0.000193	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—CDKN1A—esophageal cancer	6.73e-05	0.000191	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CREBBP—esophageal cancer	6.59e-05	0.000187	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—PIK3CA—esophageal cancer	6.51e-05	0.000184	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—EGFR—esophageal cancer	6.48e-05	0.000183	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—PIK3CA—esophageal cancer	6.47e-05	0.000183	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—EP300—esophageal cancer	6.41e-05	0.000182	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—ERBB2—esophageal cancer	6.39e-05	0.000181	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—ERBB2—esophageal cancer	6.36e-05	0.00018	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—PIK3CA—esophageal cancer	6.19e-05	0.000175	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—MYC—esophageal cancer	6.12e-05	0.000173	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—MYC—esophageal cancer	6.11e-05	0.000173	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—MYC—esophageal cancer	6.07e-05	0.000172	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—EGFR—esophageal cancer	5.98e-05	0.00017	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—EGFR—esophageal cancer	5.97e-05	0.000169	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—MYC—esophageal cancer	5.94e-05	0.000168	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—EGFR—esophageal cancer	5.94e-05	0.000168	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—NOS3—esophageal cancer	5.9e-05	0.000167	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—EGFR—esophageal cancer	5.81e-05	0.000165	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CCND1—esophageal cancer	5.64e-05	0.00016	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—PIK3CA—esophageal cancer	5.62e-05	0.000159	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CCND1—esophageal cancer	5.61e-05	0.000159	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—MYC—esophageal cancer	5.58e-05	0.000158	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—ERBB2—esophageal cancer	5.52e-05	0.000156	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—EGFR—esophageal cancer	5.46e-05	0.000155	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CDKN1A—esophageal cancer	5.46e-05	0.000155	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CDKN1A—esophageal cancer	5.43e-05	0.000154	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—EP300—esophageal cancer	5.19e-05	0.000147	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—PIK3CA—esophageal cancer	5.19e-05	0.000147	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—PIK3CA—esophageal cancer	5.19e-05	0.000147	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—EP300—esophageal cancer	5.17e-05	0.000146	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—PIK3CA—esophageal cancer	5.15e-05	0.000146	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—PIK3CA—esophageal cancer	5.04e-05	0.000143	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—TP53—esophageal cancer	5.02e-05	0.000142	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—TP53—esophageal cancer	5.02e-05	0.000142	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—TP53—esophageal cancer	4.98e-05	0.000141	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—TP53—esophageal cancer	4.88e-05	0.000138	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CCND1—esophageal cancer	4.88e-05	0.000138	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—PIK3CA—esophageal cancer	4.74e-05	0.000134	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CDKN1A—esophageal cancer	4.72e-05	0.000134	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—TP53—esophageal cancer	4.58e-05	0.00013	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—MYC—esophageal cancer	4.53e-05	0.000128	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—MYC—esophageal cancer	4.5e-05	0.000128	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—EP300—esophageal cancer	4.49e-05	0.000127	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—EGFR—esophageal cancer	4.43e-05	0.000125	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—EGFR—esophageal cancer	4.4e-05	0.000125	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—MYC—esophageal cancer	3.91e-05	0.000111	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—PIK3CA—esophageal cancer	3.84e-05	0.000109	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—EGFR—esophageal cancer	3.83e-05	0.000108	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—PIK3CA—esophageal cancer	3.82e-05	0.000108	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—TP53—esophageal cancer	3.72e-05	0.000105	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—TP53—esophageal cancer	3.7e-05	0.000105	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—PIK3CA—esophageal cancer	3.32e-05	9.41e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—TP53—esophageal cancer	3.21e-05	9.1e-05	CbGpPWpGaD
